Shaanxi Huada Science Technology Co.,Ltd.

SZSE:301517 Voorraadrapport

Marktkapitalisatie: CN¥6.1b

Shaanxi Huada Science TechnologyLtd Toekomstige groei

Future criteriumcontroles 5/6

Shaanxi Huada Science TechnologyLtd is forecast to grow earnings and revenue by 33.1% and 23.2% per annum respectively. EPS is expected to grow by 32.3% per annum. Return on equity is forecast to be 6.4% in 3 years.

Belangrijke informatie

33.1%

Groei van de winst

32.3%

Groei van de winst per aandeel

Electrical winstgroei26.1%
Inkomstengroei23.2%
Toekomstig rendement op eigen vermogen6.4%
Dekking van analisten

Low

Laatst bijgewerkt29 Oct 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Is Shaanxi Huada Science TechnologyLtd (SZSE:301517) Using Too Much Debt?

Oct 16
Is Shaanxi Huada Science TechnologyLtd (SZSE:301517) Using Too Much Debt?

Shaanxi Huada Science TechnologyLtd (SZSE:301517) Takes On Some Risk With Its Use Of Debt

Jun 14
Shaanxi Huada Science TechnologyLtd (SZSE:301517) Takes On Some Risk With Its Use Of Debt

Shaanxi Huada Science TechnologyLtd's (SZSE:301517) Earnings Are Of Questionable Quality

Apr 22
Shaanxi Huada Science TechnologyLtd's (SZSE:301517) Earnings Are Of Questionable Quality

Winst- en omzetgroeiprognoses

SZSE:301517 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,107103N/A1401
12/31/202588672N/A1271
12/31/202469353N/A671
9/30/2024677512329N/A
6/30/2024717584554N/A
3/31/202480577-74-67N/A
12/31/202385179919N/A
9/30/202383075-79-65N/A
6/30/202383164N/AN/AN/A
3/31/202381453N/AN/AN/A
1/1/202380265-43-32N/A
9/30/202281064-72-64N/A
6/30/202278573N/AN/AN/A
3/31/202277070N/AN/AN/A
12/31/202175667-50-26N/A
1/1/202163758-8312N/A
1/1/202055445-6040N/A
1/1/201950439430N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 301517's forecast earnings growth (33.1% per year) is above the savings rate (2.9%).

Winst versus markt: 301517's earnings (33.1% per year) are forecast to grow faster than the CN market (25.8% per year).

Hoge groeiwinsten: 301517's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 301517's revenue (23.2% per year) is forecast to grow faster than the CN market (14% per year).

Hoge groei-inkomsten: 301517's revenue (23.2% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 301517's Return on Equity is forecast to be low in 3 years time (6.4%).


Ontdek groeibedrijven